Roche Takes Orphan Satralizumab To EMA

Fast-Track Review Is Planned For The New Immunosuppressant

 
• By Maureen Kenny

There are six new entries on the latest list of products under review at the European Medicines Agency – products with orphan status from Roche and Novo Nordisk and four generic or biosimilars.

technology, internet, network, business concept - businessman in suit presses virtual touchscreen interface button - english word ASSESSMENT - Image
The EMA has started its review of six new marketing requests • Source: Shutterstock

More from Europe

More from Geography